GNH USA

Europe — EMA

Meropenem Aptapharma (Meropenem Trihydrate)

GNH USA supplies Meropenem Aptapharma (Meropenem), a carbapenem antibiotic for complicated intra‑abdominal infections, urinary tract infections, nosocomial

Meropenem Trihydrate

Request sourcing

1
Pack/s

What is Meropenem Trihydrate?

Meropenem, the active ingredient in Meropenem Aptapharma, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, and septicemia in hospitalized patients.

GNH USA supplies Meropenem Aptapharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Meropenem Trihydrate used for?

Meropenem is a carbapenem antibiotic used to treat serious bacterial infections.

Complicated intra‑abdominal infections: provides clinical cure and microbiological eradication. Complicated urinary tract infections: eliminates pathogenic Gram‑negative and Gram‑positive organisms. Nosocomial pneumonia: achieves rapid bacterial clearance in ventilated patients. Septicemia: controls bloodstream infections caused by susceptible bacteria.

What are the side effects of Meropenem Trihydrate?

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal discomfort. - Diarrhea: may be watery and self‑limiting. - Headache: transient and usually resolves without intervention. - Rash: mild erythematous skin eruption. - Elevated liver enzymes: transient increase in ALT/AST. - Injection site pain: local discomfort during IV administration.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Clostridioides difficile‑associated colitis: severe diarrhea and colitis. - Neutropenia or thrombocytopenia: marked reduction in blood cell counts. - Renal toxicity: acute kidney injury in predisposed individuals. - Hepatotoxicity: rare cases of liver failure.

What precautions apply to Meropenem Trihydrate?

Meropenem should be used with careful clinical monitoring. - Renal function: adjust dose in patients with impaired clearance. - Hypersensitivity: avoid in individuals with known carbapenem allergy. - Seizure risk: monitor neurologic status, especially in CNS disease. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Concomitant antibiotics: assess for additive toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Meropenem Trihydrate interact with?

Meropenem may interact with several medicines.

Major Interactions (Avoid): - Valproic acid: reduces serum levels, increasing seizure risk. - Other carbapenems: additive neurotoxicity, especially seizures. - Nephrotoxic agents (e.g., amphotericin B): heightened renal injury.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor electrolytes and renal function. - Aminoglycosides: watch for combined nephrotoxicity. - Warfarin: periodic INR checks recommended.

Frequently asked questions

What infections is Meropenem Aptapharma used to treat?+
Meropenem Aptapharma is indicated for severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired (nosocomial) pneumonia, and septicemia. It is employed when the causative organisms are susceptible and when broad‑spectrum coverage is required in hospitalized patients.
How does meropenem work to fight bacteria?+
Meropenem inhibits bacterial cell wall synthesis by binding to penicillin‑binding proteins. This blocks the cross‑linking of peptidoglycan strands, weakening the cell wall and causing osmotic lysis. The action is bactericidal and effective against many Gram‑negative, Gram‑positive, and anaerobic pathogens, including those resistant to other β‑lactams.
What is the usual dose of Meropenem Aptapharma?+
The specific dose and infusion rate of Meropenem Aptapharma are determined by the prescribing clinician based on infection severity, pathogen susceptibility, renal function, and patient weight. Healthcare providers calculate the regimen to achieve optimal therapeutic levels while minimizing toxicity.
Is Meropenem safe to use during pregnancy or breastfeeding?+
Safety data for meropenem in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. Clinicians should consider the potential benefits against possible risks and use the drug only if clearly needed. Breastfeeding mothers should consult a healthcare professional before use.
How do I order Meropenem Aptapharma from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain where required), and necessary import documentation.
How does Meropenem compare with other carbapenems?+
Meropenem shares the broad‑spectrum activity of the carbapenem class but offers a slightly lower risk of inducing seizures compared with imipenem. It is stable against many β‑lactamases and provides reliable coverage for both aerobic and anaerobic organisms, making it a preferred option when resistance to other β‑lactams is suspected.
What are the storage and handling requirements for Meropenem Aptapharma?+
Meropenem Aptapharma should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Once reconstituted, the solution should be used within the time frame specified in the product labeling and kept under the same temperature conditions during administration.
How is Meropenem Aptapharma administered?+
The product is supplied as an injectable solution for intravenous infusion. It is administered by a healthcare professional through a peripheral or central IV line, typically over a 15‑30‑minute infusion period, following the dosage instructions provided by the prescriber.
What are the most serious risks associated with Meropenem therapy?+
Serious adverse events include seizures, especially in patients with renal impairment or pre‑existing CNS disorders, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and significant hematologic abnormalities like neutropenia or thrombocytopenia. Prompt medical attention is required if any of these occur.
Who should not receive Meropenem Aptapharma?+
Patients with a documented hypersensitivity to meropenem, other carbapenems, or any β‑lactam antibiotics should avoid this product. Caution is also advised for individuals with severe renal dysfunction, a history of seizures, or those receiving valproic acid, unless the prescriber determines the benefits outweigh the risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Meropenem Trihydrate
Route
Intravenous Use
Manufacturer
Apta Medica Internacional D.O.O.
Origin
EU

Related products

Archifar

Archifar

Meropenem Trihydrate

Medochemie Romania S.R.L.
EU
Luxomer

Luxomer

Meropenem Trihydrate

Sintesy Pharma S.R.L
EU
Luxomer

Luxomer

Meropenem Trihydrate

Sintesy Pharma S.R.L
EU
Merinfec

Merinfec

Meropenem Trihydrate

Actavis Group Ptc Ehf.
EU